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Introduction
Lymphedema, swelling due to impaired flow of lymph fluid, is a result of interrupted
lymph circulation of the lymphatic system (McLafferty, Hendry, & Farley, 2012). This project
aims to review and synthesize literature regarding the physiology of the lymphatic system,
treatment of lymphedema involving the use of manual lymph drainage (MLD), and technology
advances in the use of negative pressure in treatment and intervention in lymph flow. In addition
to the literature review and synthesis, one Certified Lymphedema Therapist and physical
therapist will be interviewed and asked to provide commentary on her experience using an
advanced technology, the LymphaTouch®.
Background
Lymphatic Physiology
The lymphatic system is part of the circulatory system that carries lymph to the heart; it
also plays a major role in the immune system. It plays a key role in keeping your body healthy by
filtering out and destroying microorganisms and other dangerous substances that may enter the
body (McLafferty et al., 2012). A healthy lymphatic system fights illness and injury to keep the
body healthy (The Lymphatic System, 2010). The lymphatic system is a part of the circulatory
system that uses a one-way transport system to move lymph from body cavities and interstitial
spaces to the heart (McLafferty et al., 2012). Lymph is a watery fluid that carries fluids
throughout the lymphatic system and into the circulatory system (The Lymphatic System, 2010).
This lymph is carried through lymphatic capillaries to lymphatic vessels, to the lymph nodes,
tonsils, and spleen. (McLafferty et al., 2012). Lymphatic vessels and capillaries, similar to blood
vessels and capillaries, act as one-way valve and that prevents the backflow of fluid. Within the
lymphatic system, there are two major ducts. The right lymphatic duct drains lymph from the
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right upper quadrant of the body and the thoracic duct drains lymph from the rest of the body
(Ganong, 1993). Additionally, the system has open junctions between the endothelial cells,
which allows the lymph to move freely (Ganong, 1993). Valves allow lymph to only move
forward, not retroactively (Ganong, 1993). Lymph contains clotting factors, fats, and protein.
While lymph generally has lower protein content than plasma, it is dependent on the source of
the lymph. For example, the liver contains 6.2 g/dL of protein, whereas the skeletal muscle and
skin only have 2 g/dL and the choroid plexus and ciliary body have 0 g/dL (Ganong, 1993).
Lymph nodes are found in clusters throughout the entire lymphatic system. They are
small and are covered in connective tissue. Lymph passes through one or more node to scavenge
for bacteria and other organisms, before entering the bloodstream (The Lymphatic System, 2010).
Bacteria and other harmful substances are filtered out by macrophages and lymphocytes, but
when it cannot be removed, it causes swelling of the tissues, called lymphedema (The Lymphatic
System, 2010).
A healthy lymphatic system works to regulate homeostasis of tissue fluid, immune cell
trafficking, removal of cellular debris, and lipid absorption/transport from the gastric system
(Ridner, 2013). It also plays a large role in fluid exchange at the capillaries. It does this through
four different forces interacting including capillary pressure, negative interstitial pressure,
interstitial fluid colloid osmotic pressure, and plasma colloid osmotic pressure (Ridner, 2013). In
a healthy system, the fluid is sent into interstitial spaces because of this pressure and most of the
fluid is returned to the blood. The lymphatic system is responsible for removing any remaining
fluid in the interstitial space. If any of these four pressures are varied, it can lead to lymphedema
(Ridner, 2013).
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Lymphedema
Lymphedema occurs when the lymph within the lymphatic vessels is not removed,
causing swelling in a limb (McLafferty et al., 2012). Typically, this lymph is protein rich
(Ganong, 1993). Lymphedema can either be primary or secondary. Primary lymphedema is
caused by a genetic abnormality, whereas secondary is caused by a medical condition such as
trauma of the surgery and radiotherapy of cancerous tumors (Buragadda, Alhusaini, Melam, &
Arora, 2015). Symptoms of each of the different kinds of lymphedema blend together, so that
even if they have primary lymphedema, it may look secondary. Lymphedema can develop
shortly after cancer treatment or can present years afterward (Buragadda et al., 2015).
The diagnosis of lymphedema is key in determining how it is treated. Lymphedema is
commonly diagnosed through medical history and physical exam; however co-morbid conditions
like obesity, endocrine dysfunction, and infection may make diagnosis more difficult
(International Society of Lymphology, 2017). When patients have these co-morbid conditions,
physicians use imaging techniques like ultrasound or lymphangioscintigraphy to rule out venous
diseases, genetic testing to screen hereditary syndromes caused by gene mutations and
chromosomal abnormalities, biopsy may be necessary to examine the lymph nodes (International
Society of Lymphology, 2017).
There are different stages to differentiate between severities of lymphedema. Stage 0
occurs when there is a latent condition, but swelling is not visible (International Society of
Lymphology, 2017). In Stage 1, there is a small amount of fluid with high amounts of protein
which may cause pitting, a slight indentation in the swelling (International Society of
Lymphology, 2017). Stage 2 is characterized by pitting and elevation does not help in the
reduction of the edema (International Society of Lymphology, 2017). Finally, Stage 3 occurs
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when there is lymphostatic elephantiasis where there is no pitting, but skin is changed as a result
of the edema (International Society of Lymphology, 2017).
Treatment of Lymphedema
Treatment of lymphedema is necessary to ensure that the client is able to live a full and
meaningful life despite this condition. It is well recognized that lymphedema can be treated best
using Complete Decongestive Therapy (CDT). It aims to reduce the swelling in the limbs either
to a “normal” state or to a state where the size of the limb has stabilized (Quirion, 2009). There
are four steps within CDT- Manual Lymph Drainage (MLD), compression bandaging,
meticulous skin care, and remedial exercises/ patient education (Quirion, 2009).
MLD uses light touch to move the lymph through altering the lymph flow through
normal, healthy lymphatics and lymph node basins (Oremus, Daves, Walker, & Raina, 2012).
Bandaging and compression therapy serves a variety of different purposes. It works to open up
new lymphatic tracts and keep them stimulated, prevents the accumulation of lymph into a
recently drained lymphatic tract, and breaks up connective and scar tissue deposits (Mahran &
Moshref, 2011). After limb volume reduction, individual compression sleeves are ordered for
daily wear (Quirion, 2010).
Because the lymphatic system is so sensitive to change, careful attention to skin care is
essential for success in lymphedema management. Because the system is not working correctly
in clients with lymphedema, the body cannot easily handle infections and foreign substances,
which can cause skin breakdown (Quirion, 2010). By keeping skin clean and clear of infection,
skin damage can be avoided. The last part of CDT is remedial exercises and deep breathing to
help with venous and lymphatic flow as well as flexibility (Mahran & Moshref, 2011).
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LymphaTouch®
LymphaTouch®, a device created in 2009 by developers in Finland, was designed to use
negative pressure and high-frequency vibrations to mimic the effects of MLD (Healthy Life
Devices, 2017). LymphaTouch® can be beneficial to people with lymphedema as well as
athletes and other sport injuries (Healthy Life Devices, 2017).
LymphaTouch® operates on the principle of negative pressure (Vuorinen, Ivarinen,
Jurvelin, & Airaksinen, 2013). Negative pressure is used to stimulate fluid flow and heal fibrotic
tissues (Iivarinen, Korhonen, & Jurvelin, 2016). The operating principle behind LymphaTouch®
is that negative pressure pulls the tissue to increase lymph movement. When used,
LymphaTouch® moves the tissue vertically and horizontally in order to move the anchoring
filaments that cause the lymph to stay where it is (Healthy Life Devices, 2017). When these
filaments are moved, the endothelial cells open, causing lymph to be able to move into the
interstitial space (Healthy Life Devices, 2017). From this, the mechanism that causes lymph to
move is now activated, allowing for the lymph to be moved to another space (Healthy Life
Devices, 2017). The high frequency vibrations work to stimulate the superficial layer of the
lymphatic system, while the lower frequency vibrations work to stimulate the deep layer of the
lymphatic system (Healthy Life Devices, 2017).
One study done by Vuorinen, Ivarinen, Jurvelin, and Airaksinen (2013) looked at
different diagnostic measurements in 13 women who had upper extremity lymphedema as a
result of a mastectomy. Researchers looked at range of motion, volumetric limb measurement,
quality of life, limb volume, as well as many other measurements to determine outcomes.
Participants were split into either a LymphaTouch® group or a MLD group. Each participant
had ten treatments in their respective groups, which lasted for 90 minutes each. This study found
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significant changes in tissue stiffness and degree of disability in the LymphaTouch® group
relative to the MLD group (Vuorinen et al., 2013). Additionally, the MRI measurements of limb
volume show that muscle tissue edema decreased by 7% following LymphaTouch® treatment.
It also found that the two groups had similar results in mobility, grip strength, circumferences, or
body fluid changes (Vuorinen et al., 2013). These results suggest that LymphaTouch® may be a
positive and safe treatment that does not have any adverse effects.
Another study also suggests that LymphaTouch® has an effect on soft tissue.
Researchers tested a forearm while resting and while experiencing venous occlusion. It was
found that when the tissue swells, the skin and adipose tissue stiffen at around the same time. It
also found that skin stretch is more sensitive than adipose tissue (Iivarinen, Korhonen, Julkunen,
& Jurvelin, 2013). This study suggests that there may be a benefit in LymphaTouch® and its
role in diagnosis and screening for changes in soft tissue in addition to lymphedema and other
swelling conditions (Iivarinen et al., 2013).
In a study by Airakisinen, Vuorinen, and Raittila (2011), 18 patients were treated with
LymphaTouch® and their edema and perceived pain was measured before and after treatments.
This study used the LymphaTouch® protocol for a 20 minute treatment session. Patients with
shoulder, neck, and knee edema showed a significant decrease in pain after 6 weeks of sessions
(Airaksinen, 2011). Patients with elbow edema showed a moderate pain decrease. Additionally,
edema was decreased with each session (Airaksinen, 2011). All of the patients felt that
LymphaTouch® was helpful and that they never felt discomfort from it (Airaksinen, 2011).
Although this study did not specifically look at limb volume, but rather pain, the authors still
suggest that LymphaTouch® may be a safe form of pain reduction (Airaksinen, 2011).
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Iivarinen, Korhonen, & Jurvelin (2016) looked how two different LymphaTouch®
negative pressure protocols affected tissue swelling. Eleven participants were placed into either
cyclic or continuous protocols. Cyclic pressure occurs when the pressure is varied to allow the
skin to move, stop, then return back to normal. Continuous pressure occurs when the pressure
stays the same throughout the entire treatment session. The continuous protocol showed higher
fluid pressure and more effective fluid movement than the cyclic protocol (Iivarinen et al., 2016).
This study suggests that negative pressure models may be beneficial in increasing free movement
of fluid (Iivarinen et al., 2016).
Osborne & Newell (2015) looked at how effective LymphaTouch® is in increasing
function of lymphatics. They used two different phases- subfascial and superficial intervention,
in order to reach both the deep and superficial lymphatic systems (Osborne & Newell, 2015). In
the subfascial intervention, lymph was drained from deep structures like joint synovia nerves and
muscles (Osborne & Newell, 2015). The purpose of this was to move the lymph from the deep
system to the superficial system (Osborne & Newell, 2015). Then, the superficial intervention
strengthens the gaps and filaments to allow the lymph to move smoother (Osborne & Newell,
2015). This treatment, using LymphaTouch®, reduced inflammation, reduced proteolytic
activity, and reduced adipose tissue and fibrosis (Osborne & Newell, 2015).
Therapist’s Perspective
To gain a stronger understanding of LymphaTouch®, Maureen McBeth, MPT, CLTLANA, a physical therapist and Certified Lymphedema Therapist at Mercy Medical Center, was
interviewed. McBeth has been working with patients with lymphedema for 14 years and using
LymphaTouch® for 5. Convenience sampling was used to find this participant, as she was a
colleague of the faculty advisor. With IRB approval from Elizabethtown College and receiving
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consent to use her name, a semi-structured interview was conducted to gain clinical commentary
about the device. The interview took place over the phone and the questions were open ended, to
allow the participant the option to add her own stories. The interview questions were designed to
connect results from research studies to McBeth’s experiences in the clinic.
She states that it is difficult to compare MLD from LymphaTouch® because they are so
different (M. McBeth, personal communication, April 9, 2018). McBeth also says that MLD
calms down the whole nervous system through constant contact. LymphaTouch® activates the
lymphatic system, but affects the local tissues of the area as well. McBeth also found that when
the device does not move, it can help identify areas that need to be addressed (personal
communication, April 9, 2018). This is consistent with the Iivarinen et al. (2013) study that
suggests that LymphaTouch® is effective in diagnosis and detecting changes in soft tissue.
Additionally, McBeth states that she finds that patients respond best to treatment when the
device is used with cyclic pressure (personal communication, April 9, 2018). Iivarinen et al.
(2016) suggested that continuous pressure was better because it allowed for more fluid
movement, so more research should be conducted on this with more participants.
Additionally, in McBeth’s opinion, LymphaTouch® works best when used along with
MLD. By controlling pressure, static/dynamic properties, vibration, and physical effects, it can
treat many different side effects of cancer treatment (M. McBeth, personal communication, April
9, 2018). She suggests that LymphaTouch® can help patients with lymphedema, cording,
peripheral neuropathy, and other sensory deficiencies. While studies regarding LymphaTouch®
and these side effects have not yet been done, McBeth says that “LymphaTouch® can help you
adapt to all of those problems.” Even though there are not settings to differentiate treating each
different side effect, it simultaneously treats all of them at the same time.
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When asked what challenges she has faced while using this technology, McBeth stated
that the mechanical design could use work. After 5 years of usage, the plastic handle is cracked,
but all challenges are related to the durability of the product, not the outcomes of it. She also
stated that she has been working with the creators of LymphaTouch® to improve the overall
design of the machine. Although she does not know the exact number of patients she has treated
with LymphaTouch®, McBeth stated that she has never had a patient who had a negative
response to the treatment. She added that patients with sensitive skin or is taking blood thinners
may be more likely to have a “cupping” effect on their skin that causes discomfort, not pain (M.
McBeth, personal communication, April 9, 2018). In the Vuorinen et al. (2013) research, they
also found their participants did not have any adverse side effects or pain from the treatment.
Because LymphaTouch® acts as an “extra set of hands”, many patients have bought one
for their home. This would make treatment possible at home, with the proper training.
Additionally, McBeth adds that surgeons have used it prior to trauma surgeries to help decrease
edema before going into surgery. McBeth also mentions that LymphaTouch® can be used in
early intervention to see if the patient is having any subtle changes and helps to treat them early
(personal communication, April 9, 2018). In the Iivarinen et al. (2013) research, it was found
that LymphaTouch® can be used to help diagnose and treat early, similar to what McBeth
mentioned.
Overall, McBeth spoke highly of LymphaTouch®, stating that it had many benefits to
both therapists and patients. When used in conjunction with Kinesio Tape, bandaging,
compression therapy, and other modalities, LymphaTouch® shows promise in decreasing
lymphedema symptoms (M. McBeth, personal communication, April 9, 2018).
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Conclusion
The literature and the clinical commentary from Maureen McBeth suggest that
LymphaTouch® might have benefits for patients who are undergoing Complete Decongestive
Therapy to treat tissue stiffness, pain, and improve lymph flow. The clinical commentary gained
from McBeth suggested that the device may have other benefits, however more research needs to
be conducted. While this study showed that LymphaTouch® may be beneficial for clients;
however, there are limitations. Only one therapist was interviewed to gain clinical commentary.
Because only one therapist was interviewed, her commentary cannot be generalized to all
therapists that use LymphaTouch®. To gain more evidence on LymphaTouch® research should
be conducted to determine its effectiveness in decreasing cording, neuropathy, as well as other
sensory deficiencies. Additionally, research should be conducted to determine the patients’
perspectives on LymphaTouch®. Overall, the literature and clinical commentary suggest that
LymphaTouch® could be a beneficial device to use for CDT, but more research should be
conducted to find its effectiveness for other conditions.
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